FMC Corp vs Lemonade Inc — how do they compare? FMC Corp trades at $11.16 (market cap $1.36B), while Lemonade Inc trades at $68.1 (market cap $5.07B). The key difference: Lemonade Inc is far larger — about 3.7× FMC Corp's market cap, and FMC Corp pays a 2.95% dividend while Lemonade Inc pays none. Which is the better fit depends on your goals.
| FMC | LMND | |
|---|---|---|
Market Cap | $1.36B | $5.07B |
Sector | Basic Materials | Financials |
52-Week High | $43.90 | $96.57 |
52-Week Low | $10.72 | $36.28 |
Enterprise Value | $5.50B | $4.90B |
Dividend Yield | 2.95% | — |
Signals from Pluang's Aura AI — not financial advice
FMC Corporation (FMC) trades at $10.72, down 1.74% on the day, reflecting ongoing challenges despite recent strategic moves. The stock shows a bearish technical trend with oversold RSI signals, while fundamentals reveal significant pressure with a net income margin of -72.93% and negative ROE of -80.78% for 2025. Recent developments include a $400 million minority investment from Tessenderlo Group and regulatory submission for new herbicide rimisoxafen, providing some operational support amid financial restructuring.
The outlook remains cautious with analyst consensus leaning neutral (50% Hold) despite a $16 price target suggesting 49% upside. Key risks include persistent revenue declines, high debt levels, and negative cash flow from operations. Investment opportunity exists if new product approvals and debt reduction efforts successfully stabilize profitability, but current financial metrics indicate substantial execution risk near term.
LMND trades at $70.14, down 0.68% on the day, with a bullish technical signal supported by moving averages. The company shows accelerating revenue growth, reaching $737.9M in 2025, while narrowing net losses. Recent expansion into new states and a renegotiated reinsurance program highlight operational momentum, though profitability remains negative.
The outlook balances growth potential against persistent losses. Investment appeal hinges on continued premium expansion and path to profitability, but risks include high valuation multiples and competitive pressures. Analyst sentiment is mixed, with a $69.60 consensus target slightly below the current price.
Trailing returns across standard periods
Latest headlines on both assets
FMC is a pure-play crop chemical company. The company has diversified its sales to create a balanced crop chemical portfolio across geographies and crop exposure. Through acquisitions, FMC is now one of the five largest patented crop chemical companies and will continue to develop new products, with a focus on biologicals, through its research and development pipeline.
Read more on FMC →Lemonade Inc operates in the insurance industry. The company offers digital and artificial intelligence based platform for various insurances and for settling claims and paying premiums. The platform ensures transparency in issuing policies and settling disputes.
Read more on LMND →